Evidence map›Paper›PMID 39354262›Full record

ArticleTissue engineering and regenerative medicine2024

Perfusion Bioreactor Conditioning of Small-diameter Plant-based Vascular Grafts.

Nicole Gorbenko, John C Vaccaro, Ryan Fagan, Robert A Cerro, Jonah M Khorrami, Lucia Galindo, Nick Merna

Abstract read
In one paragraph

Article in Tissue engineering and regenerative medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Optimization and Standardization of Plant-Derived Vascular Scaffolds.International journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nicole GorbenkoBioengineering Program, Fred DeMatteis School of Engineering and Applied Science, Hofstra University, 229 Science and Innovation Center, Hempstead, NY, 11549, USA.
John C VaccaroMechanical Engineering Program, Fred DeMatteis School of Engineering and Applied Science, Hofstra University, 200B Weed Hall, Hempstead, NY, 11549, USA.
Ryan FaganBioengineering Program, Fred DeMatteis School of Engineering and Applied Science, Hofstra University, 229 Science and Innovation Center, Hempstead, NY, 11549, USA.
Robert A CerroFred DeMatteis School of Engineering and Applied Science, Hofstra University, 016 Adams Hall, Hempstead, NY, 11549, USA.
Jonah M KhorramiBioengineering Program, Fred DeMatteis School of Engineering and Applied Science, Hofstra University, 229 Science and Innovation Center, Hempstead, NY, 11549, USA.
Lucia GalindoBioengineering Program, Fred DeMatteis School of Engineering and Applied Science, Hofstra University, 229 Science and Innovation Center, Hempstead, NY, 11549, USA.ORCID 0009-0001-5361-7042
Nick MernaBioengineering Program, Fred DeMatteis School of Engineering and Applied Science, Hofstra University, 229 Science and Innovation Center, Hempstead, NY, 11549, USA. Nicholas.J.Merna@hofstra.edu.ORCID 0000-0002-3463-2538

Funding

Tissue Engineering Plant-based Vascular Grafts IIR15EB033168 · NIBIB · HOFSTRA UNIVERSITY · PI MERNA, NICHOLAS J. · 2022 to 2025
$888k
NIBIB NIH HHS R15 EB033168NIBIB NIH HHS R15EB033168
6 · The paper itself

Abstract

backgroundVascular grafts are mainly composed of synthetic materials, but are prone to thrombosis and intimal hyperplasia at small diameters. Decellularized plant scaffolds have emerged that provide promising alternatives for tissue engineering. We previously developed robust, endothelialized small-diameter vessels from decellularized leatherleaf viburnum. This is the first study to precondition and analyze plant-based vessels under physiological fluid flow and pressure waveforms. Using decellularized leatherleaf viburnum as tissue-engineered grafts for implantation can have profound impacts on healthcare due to their biocompatibility and cost-effective production.

methodsA novel perfusion bioreactor was designed, capable of accurately controlling fluid flow rate and pressure waveforms for preconditioning of small-diameter vascular grafts. A closed-loop system controlled pressure waveforms, mimicking physiological values of 50-120 mmHg at a frequency of 8.75 Hz for fluid flow reaching 5 mL/min. Plant-based vascular grafts were recellularized with endothelial and vascular smooth muscle cells and cultured for up to 3 weeks in this bioreactor. Cell density, scaffold structure and mechanics, thrombogenicity, and immunogenicity of grafts were evaluated.

resultsBioreactor treatment with fluid flow significantly increased luminal endothelial cell density, while pressure waveforms reduced thrombus formation and maintained viable vascular smooth muscle cells within inner layers of grafts compared to static controls. Suture retention of grafts met transplantation standards and white cell viability was suitable for vascular remodeling.

conclusionLow thrombogenicity of endothelialized leatherleaf viburnum holds great potential for vascular repair. This study provides insight into benefits of conditioning plant-based materials with hemodynamic forces at higher frequencies that have not previously been investigated.

Indexed as

BioreactorsBlood Vessel ProsthesisAnimalsEndothelial CellsHumansMuscle, Smooth, VascularMyocytes, Smooth MusclePerfusionTissue EngineeringTissue ScaffoldsBioreactorPlantTissue engineeringVascular graft

Identifiers

PMID39354262
PMCPMC11589060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.